Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Mary Potter Oncology Center

     
Pretoria , Gauteng
South Africa

 

Principal Investigator:
G. L. Cohen, MD
Contact:
Erika Bosch +27-12-346-6701 ericka.bosch@mpoc.co.za
Activation Status of this Site:
Closed
Notes about this Site:
Mary Potter Oncology Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.